Interferon alpha in systemic lupus erythematosus

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Poole, Brian D ^b   Niewold, Timothy B ^a   Clark, Daniel N ^b   Salloum, Rafah ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON REGULATORY FACTOR; TOLL LIKE RECEPTOR; AUTOANTIBODY;

GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; IMMUNE RESPONSE; REVIEW; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; PATHOPHYSIOLOGY;

ANIMALS; AUTOANTIBODIES; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE;

EID: 77955350698     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/948364     Document Type: Review

References (89)

1. Fitzgerald-Bocarsly P., Dai J., Singh S., Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history Cytokine and Growth Factor Reviews 2008 19 1 3 19
2. Ito T., Wang Y.-H., Liu Y.-J., Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9 Springer Seminars in Immunopathology 2005 26 3 221 229
3. Lvgren T., Eloranta M.-L., Kastner B., Wahren-Herlenius M., Alm G. V., Rnnblom L., Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA Arthritis and Rheumatism 2006 54 6 1917 1927
4. Schoenemeyer A., Barnes B. J., Mancl M. E., Latz E., Goutagny N., Pitha P. M., Fitzgerald K. A., Golenbock D. T., The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling Journal of Biological Chemistry 2005 280 17 17005 17012
5. Hoshino K., Sugiyama T., Matsumoto M., Tanaka T., Saito M., Hemmi H., Ohara O., Akira S., Kaisho T., I B kinase-α is critical for interferon- production induced by Toll-like receptors 7 and 9 Nature 2006 440 7086 949 953
6. Kawai T., Sato S., Ishii K. J., Coban C., Hemmi H., Yamamoto M., Terai K., Matsuda M., Inoue J.-I., Uematsu S., Takeuchi O., Akira S., Interferon- induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 Nature Immunology 2004 5 10 1061 1068
7. Lseke S., Grage-Griebenow E., Heine H., Wagner A., Akira S., Bauer S., Bufe A., In vitro-generated viral double-stranded RNA in contrast to polyinosinic: polycytidylic acid induces interferon- in human plasmacytoid dendritic cells Scandinavian Journal of Immunology 2006 63 4 264 274
8. Fairhurst A.-M., Hwang S.-H., Wang A., Tian X.-H., Boudreaux C., Zhou X. J., Casco J., Li Q.-Z., Connolly J. E., Wakeland E. K., Yaa autoimmune phenotypes are conferred by overexpression of TLR7 European Journal of Immunology 2008 38 7 1971 1978
9. Pisitkun P., Deane J. A., Difilippantonio M. J., Tarasenko T., Satterthwaite A. B., Bolland S., Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication Science 2006 312 5780 1669 1672
10. Subramanian S., Tus K., Li Q.-Z., Wang A., Tian X.-H., Zhou J., Liang C., Bartov G., McDaniel L. D., Zhou X. J., Schultz R. A., Wakeland E. K., A Tlr7 translocation accelerates systemic autoimmunity in murine lupus Proceedings of the National Academy of Sciences of the United States of America 2006 103 26 9970 9975
11. Ramanujam M., Kahn P., Huang W., Tao H., Madaio M. P., Factor S. M., Davidson A., Interferon- treatment of Female (NZW BXSB)F1 mice mimics some but not all features associated with the Yaa mutation Arthritis and Rheumatism 2009 60 4 1096 1101
12. Barrat F. J., Meeker T., Chan J. H., Guiducci C., Coffmann R. L., Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms European Journal of Immunology 2007 37 12 3582 3586
13. Barrat F. J., Meeker T., Gregorio J., Chan J. H., Uematsu S., Akira S., Chang B., Duramad O., Coffman R. L., Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus Journal of Experimental Medicine 2005 202 8 1131 1139
14. Batteux F., Palmer P., Daron M., Weill B., Lebon P., FC RII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus European Cytokine Network 1999 10 4 509 514
15. Bve U., Magnusson M., Eloranta M.-L., Perers A., Alm G. V., Rnnblom L., Fc RIIa is expressed on natural IFN- -producing cells (plasmacytoid dendritic cells) and is required for the IFN- production induced by apoptotic cells combined with Lupus IgG Journal of Immunology 2003 171 6 3296 3302
16. Savarese E., Chae O.-W., Trowitzsch S., Weber G., Kastner B., Akira S., Wagner H., Schmid R. M., Bauer S., Krug A., U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7 Blood 2006 107 8 3229 3234
17. Rajagopal D., Paturel C., Morel Y., Uematsu S., Akira S., Diebold S. S., Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists Blood 2010 115 10 1949 1957
18. Asselin-Paturel C., Brizard G., Chemin K., Boonstra A., O'Garra A., Vicari A., Trinchieri G., Type I interferon dependence of plasmacytoid dendritic cell activation and migration Journal of Experimental Medicine 2005 201 7 1157 1167
19. Niewold T. B., Rivera T. L., Buyon J. P., Crow M. K., Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus Arthritis and Rheumatism 2008 58 2 541 546
20. Farkas A., Tonel G., Nestle F. O., Interferon- and viral triggers promote functional maturation of human monocyte-derived dendritic cells British Journal of Dermatology 2008 158 5 921 929
21. Sakakibara M., Kanto T., Inoue M., Kaimori A., Yakushijin T., Miyatake H., Itose I., Miyazaki M., Kuzushita N., Hiramatsu N., Takehara T., Kasahara A., Hayashi N., Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon- as potent immune enhancers Journal of Immunotherapy 2006 29 1 67 77
22. Blanco P., Palucka A. K., Gill M., Pascual V., Banchereau J., Induction of dendritic cell differentiation by IFN- in systemic lupus erythematosus Science 2001 294 5546 1540 1543
23. Ito T., Amakawa R., Inaba M., Hori T., Ota M., Nakamura K., Takebayashi M., Miyaji M., Yoshimura T., Inaba K., Fukuhara S., Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs Journal of Immunology 2004 172 7 4253 4259
24. Mohty M., Vialle-Castellano A., Nunes J. A., Isnardon D., Olive D., Gaugler B., IFN- skews monocyte differentiation into toll-like receptor 7-expressing dendritic cells with potent functional activities Journal of Immunology 2003 171 7 3385 3393
25. Cucak H., Yrlid U., Reizis B., Kalinke U., Johansson-Lindbom B., Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells Immunity 2009 31 3 491 501
26. Barth S., Soltsz P., Kiss E., Aleksza M., Zeher M., Szegedi G., Sipka S., The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25highFoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients Autoimmunity 2007 40 7 521 528
27. Bonelli M., Savitskaya A., Von Dalwigk K., Steiner C. W., Aletaha D., Smolen J. S., Scheinecker C., Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE) International Immunology 2008 20 7 861 868
28. Hu S., Xiao W., Kong F., Ke D., Qin R., Su M., Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus Journal of Huazhong University of Science and TechnologyMedical Science 2008 28 5 549 552
29. Suen J.-L., Li H.-T., Jong Y.-J., Chiang B.-L., Yen J.-H., Altered homeostasis of CD4+FoxP3+ regulatory T-cell subpopulations in systemic lupus erythematosus Immunology 2009 127 2 196 205
30. Venigalla R. K. C., Tretter T., Krienke S., Max R., Eckstein V., Blank N., Fiehn C., Ho A. D., Lorenz H.-M., Reduced CD4+,CD25-T cell sensitivity to the suppressive function of CD4+,CD25high,CD127-/low regulatory T cells in patients with active systemic lupus erythematosus Arthritis and Rheumatism 2008 58 7 2120 2130
31. Yates J., Whittington A., Mitchell P., Lechler R. I., Lightstone L., Lombardi G., Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis Clinical and Experimental Immunology 2008 153 1 44 55
32. Gmez J., Prado C., Lpez P., Surez A., Gutirrez C., Conserved anti-proliferative effect and poor inhibition of TNF secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus Clinical Immunology 2009 132 3 385 392
33. Gigante M., Mandic M., Wesa A. K., Cavalcanti E., Dambrosio M., Mancini V., Battaglia M., Gesualdo L., Storkus W. J., Ranieri E., Interferon-alpha (IFN- )-conditioned DC preferentially stimulate type-1 and limit treg-type in vitro T-cell responses from RCC patients Journal of Immunotherapy 2008 31 3 254 262
34. Yan B., Ye S., Chen G., Kuang M., Shen N., Chen S., Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon- -producing antigen-presenting cells Arthritis and Rheumatism 2008 58 3 801 812
35. Ruuth K., Carlsson L., Hallberg B., Lundgren E., Interferon- promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase Biochemical and Biophysical Research Communications 2001 284 3 583 586
36. Oka H., Hirohata S., Inoue T., Ito K., Effects of interferon- on human B cell responsiveness: biphasic effects in cultures stimulated with Staphylococcus aureus Cellular Immunology 1992 139 2 478 492
37. Oka H., Hirohata S., Regulation of human B cell responsiveness by interferon- : interferon- -mediated suppression of B cell function is reversed through direct interactions between monocytes and B cells Cellular Immunology 1993 146 2 238 248
38. Alarcn-Segovia D., Alarcn-Riquelme M. E., Cardiel M. H., Caeiro F., Massardo L., Villa A. R., Pons-Estel B. A., Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort Arthritis and Rheumatism 2005 52 4 1138 1147
39. Deapen D., Escalante A., Weinrib L., Horwitz D., Bachman B., Roy-Burman P., Walker A., Mack T. M., A revised estimate of twin concordance in systemic lupus erythematosus Arthritis and Rheumatism 1992 35 3 311 318
40. Wandstrat A., Wakeland E., The genetics of complex autoimmune diseases: non-MHC susceptibility genes Nature Immunology 2001 2 9 802 809
41. Sebastiani G. D., Galeazzi M., Immunogenetic studies on systemic lupus erythematosus Lupus 2009 18 10 878 883
42. Moser K. L., Kelly J. A., Lessard C. J., Harley J. B., Recent insights into the genetic basis of systemic lupus erythematosus Genes and Immunity 2009 10 5 373 379
43. Harley I. T. W., Kaufman K. M., Langefeld C. D., Harley J. B., Kelly J. A., Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies Nature Reviews Genetics 2009 10 5 285 290
44. Graham R. R., Hom G., Ortmann W., Behrens T. W., Review of recent genome-wide association scans in lupus Journal of Internal Medicine 2009 265 6 680 688
45. Rhodes B., Vyse T. J., The genetics of SLE: an update in the light of genome-wide association studies Rheumatology 2008 47 11 1603 1611
46. Lee Y. H., Song G. G., Association between the rs2004640 functional polymorphism of interferon regulatory factor 5 and systemic lupus erythematosus: a meta-analysis Rheumatology International 2009 29 10 1137 1142
47. Kawasaki A., Kyogoku C., Ohashi J., Miyashita R., Hikami K., Kusaoi M., Tokunaga K., Takasaki Y., Hashimoto H., Behrens T. W., Tsuchiya N., Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms Arthritis and Rheumatism 2008 58 3 826 834
48. Kelly J. A., Kelley J. M., Kaufman K. M., Kilpatrick J., Bruner G. R., Merrill J. T., James J. A., Frank S. G., Reams E., Brown E. E., Gibson A. W., Marion M. C., Langefeld C. D., Li Q.-Z., Karp D. R., Wakeland E. K., Petri M., Ramsey-Goldman R., Reveille J. D., Vil L. M., Alarcn G. S., Kimberly R. P., Harley J. B., Edberg J. C., Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans Genes and Immunity 2008 9 3 187 194
49. Reddy M. V. P. L., Velzquez-Cruz R., Baca V., Lima G., Granados J., Orozco L., Alarcn-Riquelme M. E., Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans Human Genetics 2007 121 6 721 727
50. Shimane K., Kochi Y., Yamada R., Okada Y., Suzuki A., Miyatake A., Kubo M., Nakamura Y., Yamamoto K., A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population Annals of the Rheumatic Diseases 2009 68 3 377 383
51. Graham R. R., Kyogoku C., Sigurdsson S., Vlasova I. A., Davies L. R. L., Baechler E. C., Plenge R. M., Koeuth T., Ortmann W. A., Hom G., Bauer J. W., Gillett C., Burtt N., Graham D. S. C., Onofrio R., Petri M., Gunnarsson I., Svenungsson E., Rnnblom L., Nordmark G., Gregersen P. K., Moser K., Gaffney P. M., Criswell L. A., Vyse T. J., Syvnen A.-C., Bohjanen P. R., Daly M. J., Behrens T. W., Altshuler D., Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus Proceedings of the National Academy of Sciences of the United States of America 2007 104 16 6758 6763
52. Graham R. R., Kyogoku C., Sigurdsson S., Vlasova I. A., Davies L. R. L., Baechler E. C., Plenge R. M., Koeuth T., Ortmann W. A., Hom G., Bauer J. W., Gillett C., Burtt N., Graham D. S. C., Onofrio R., Petri M., Gunnarsson I., Svenungsson E., Rnnblom L., Nordmark G., Gregersen P. K., Moser K., Gaffney P. M., Criswell L. A., Vyse T. J., Syvnen A.-C., Bohjanen P. R., Daly M. J., Behrens T. W., Altshuler D., Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus Proceedings of the National Academy of Sciences of the United States of America 2007 104 16 6758 6763
53. Niewold T. B., Kelly J. A., Flesch M. H., Espinoza L. R., Harley J. B., Crow M. K., Association of the IRF5 risk haplotype with high serum interferon- activity in systemic lupus erythematosus patients Arthritis and Rheumatism 2008 58 8 2481 2487
54. Harley J. B., Alarcn-Riquelme M. E., Criswell L. A., Jacob C. O., Kimberly R. P., Moser K. L., Tsao B. P., Vyse T. J., Langefeld C. D., Nath S. K., Guthridge J. M., Cobb B. L., Mirel D. B., Marion M. C., Williams A. H., Divers J., Wang W., Frank S. G., Namjou B., Gabriel S. B., Lee A. T., Gregersen P. K., Behrens T. W., Taylor K. E., Fernando M., Zidovetzki R., Gaffney P. M., Edberg J. C., Rioux J. D., Ojwang J. O., James J. A., Merrill J. T., Gilkeson G. S., Seldin M. F., Yin H., Baechler E. C., Li Q.-Z., Wakeland E. K., Bruner G. R., Kaufman K. M., Kelly J. A., Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci Nature Genetics 2008 40 2 204 210
55. Suarez-Gestal M., Calaza M., Endreffy E., Pullmann R. Jr., Ordi-Ros J., Domenico Sebastiani G., Ruzickova S., Jose Santos M., Papasteriades C., Marchini M., Skopouli F. N., Suarez A., Blanco F. J., D'Alfonso S., Bijl M., Carreira P., Witte T., Migliaresi S., Gomez-Reino J. J., Gonzalez A., Kovacs A., Balada E., Dostal C., Vinagre F., Kappou-Rigatou I., Scorza R., Mavromati M., Gutierrez C., Rego I., Barizzone N., Kallenberg C. G., Schmidt R. E., Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study Arthritis Research and Therapy 2009 11 3, article 69
56. Salloum R., Franek B., Kariuki S., Utset T., Niewold T. T., Genetic variation at the IRF7/KIAA1542 locus is associated with autoantibody profile and serum interferon alpha levels in lupus patients Clinical Immunology 2009 131 supplement 1 S54
57. Armstrong D. L., Reiff A., Myones B. L., Quismorio F. P. Jr., Klein-Gitelman M., McCurdy D., Wagner-Weiner L., Silverman E., Ojwang J. O., Kaufman K. M., Kelly J. A., Merrill J. T., Harley J. B., Bae S.-C., Vyse T. J., Gilkeson G. S., Gaffney P. M., Moser K. L., Putterman C., Edberg J. C., Brown E. E., Ziegler J., Langefeld C. D., Zidovetzki R., Jacob C. O., Identification of new SLE-associated genes with a two-step Bayesian study design Genes and Immunity 2009 10 5 446 456
58. Xu C.-J., Zhang W.-H., Pan H.-F., Li X.-P., Xu J.-H., Ye D.-Q., Association study of a single nucleotide polymorphism in the exon 2 region of toll-like receptor 9 (TLR9) gene with susceptibility to systemic lupus erythematosus among Chinese Molecular Biology Reports 2009 36 8 2245 2248
59. Jacob C. O., Zhu J., Armstrong D. L., Yan M., Han J., Zhou X. J., Thomas J. A., Reiff A., Myones B. L., Ojwang J. O., Kaufman K. M., Klein-Gitelman M., McCurdy D., Wagner-Weiner L., Silverman E., Ziegler J., Kelly J. A., Merrill J. T., Harley J. B., Ramsey-Goldman R., Vila L. M., Bae S.-C., Vyse T. J., Gilkeson G. S., Gaffney P. M., Moser K. L., Langefeld C. D., Zidovetzki R., Mohan C., Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus Proceedings of the National Academy of Sciences of the United States of America 2009 106 15 6256 6261
60. Bates J. S., Lessard C. J., Leon J. M., Nguyen T., Battiest L. J., Rodgers J., Kaufman K. M., James J. A., Gilkeson G. S., Kelly J. A., Humphrey M. B., Harley J. B., Gray-McGuire C., Moser K. L., Gaffney P. M., Meta-analysis and imputation identifies a 109kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations Genes and Immunity 2009 10 5 470 477
61. Gateva V., Sandling J. K., Hom G., Taylor K. E., Chung S. A., Sun X., Ortmann W., Kosoy R., Ferreira R. C., Nordmark G., Gunnarsson I., Svenungsson E., Padyukov L., Sturfelt G., Jnsen A., Bengtsson A. A., Rantap-Dahlqvist S., Baechler E. C., Brown E. E., Alarcn G. S., Edberg J. C., Ramsey-Goldman R., McGwin G., Reveille J. D., Vil L. M., Kimberly R. P., Manzi S., Petri M. A., Lee A., Gregersen P. K., Seldin M. F., Rnnblom L., Criswell L. A., Syvnen A.-C., Behrens T. W., Graham R. R., A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus Nature Genetics 2009 41 11 1228 1233
62. Graham R. R., Cotsapas C., Davies L., Hackett R., Lessard C. J., Leon J. M., Burtt N. P., Guiducci C., Parkin M., Gates C., Plenge R. M., Behrens T. W., Wither J. E., Rioux J. D., Fortin P. R., Cunninghame Graham D., Wong A. K., Vyse T. J., Daly M. J., Altshuler D., Moser K. L., Gaffney P. M., Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus Nature Genetics 2008 40 9 1059 1061
63. Han J.-W., Zheng H.-F., Cui Y., Sun L.-D., Ye D.-Q., Hu Z., Xu J.-H., Cai Z.-M., Huang W., Zhao G.-P., Xie H.-F., Fang H., Lu Q.-J., Xu J.-H., Li X.-P., Pan Y.-F., Deng D.-Q., Zeng F.-Q., Ye Z.-Z., Zhang X.-Y., Wang Q.-W., Hao F., Ma L., Zuo X.-B., Zhou F.-S., Du W.-H., Cheng Y.-L., Yang J.-Q., Shen S.-K., Li J., Sheng Y.-J., Zuo X.-X., Zhu W.-F., Gao F., Zhang P.-L., Guo Q., Li B., Gao M., Xiao F.-L., Quan C., Zhang C., Zhang Z., Zhu K.-J., Li Y., Hu D.-Y., Lu W.-S., Huang J.-L., Liu S.-X., Li H., Ren Y.-Q., Wang Z.-X., Yang C.-J., Wang P.-G., Zhou W.-M., Lv Y.-M., Zhang A.-P., Zhang S.-Q., Lin D., Li Y., Low H. Q., Shen M., Zhai Z.-F., Wang Y., Zhang F.-Y., Yang S., Liu J.-J., Zhang X.-J., Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus Nature Genetics 2009 41 11 1234 1237
64. Musone S. L., Taylor K. E., Lu T. T., Nititham J., Ferreira R. C., Ortmann W., Shifrin N., Petri M. A., Ilyas Kamboh M., Manzi S., Seldin M. F., Gregersen P. K., Behrens T. W., Ma A., Kwok P.-Y., Criswell L. A., Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus Nature Genetics 2008 40 9 1062 1064
65. Honma K., Tsuzuki S., Nakagawa M., Tagawa H., Nakamura S., Morishima Y., Seto M., TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas Blood 2009 114 12 2467 2475
66. Kato M., Sanada M., Kato I., Sato Y., Takita J., Takeuchi K., Niwa A., Chen Y., Nakazaki K., Nomoto J., Asakura Y., Muto S., Tamura A., Iio M., Akatsuka Y., Hayashi Y., Mori H., Igarashi T., Kurokawa M., Chiba S., Mori S., Ishikawa Y., Okamoto K., Tobinai K., Nakagama H., Nakahata T., Yoshino T., Kobayashi Y., Ogawa S., Frequent inactivation of A20 in B-cell lymphomas Nature 2009 459 7247 712 716
67. Kariuki S. N., Kirou K. A., MacDermott E. J., Barillas-Arias L., Crow M. K., Niewold T. B., Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo Journal of Immunology 2009 182 1 34 38
68. Abelson A. K., Delgado-Vega A. M., Kozyrev S. V., Snchez E., Velzquez-Cruz R., Eriksson N., Wojcik J., Linga Reddy M. V., Lima G., D'Alfonso S., Migliaresi S., Baca V., Orozco L., Witte T., Ortego-Centeno N., Abderrahim H., Pons-Estel B. A., Gutirrez C., Surez A., Gonzlez-Escribano M. F., Martin J., Alarcn-Riquelme M. E., STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk Annals of the Rheumatic Diseases 2009 68 11 1746 1753
69. Sigurdsson S., Nordmark G., Garnier S., Grundberg E., Kwan T., Nilsson O., Eloranta M.-L., Gunnarsson I., Svenungsson E., Sturfelt G., Bengtsson A. A., Jnsen A., Truedsson L., Rantap-Dahlqvist S., Eriksson C., Alm G., Gring H. H. H., Pastinen T., Syvnen A.-C., Rnnblom L., A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5 Human Molecular Genetics 2008 17 18 2868 2876
70. Cao W., Liu Y.-J., Opn: key regulator of pDC interferon production Nature Immunology 2006 7 5 441 443
71. Kariuki S. N., Moore J. G., Kirou K. A., Crow M. K., Utset T. O., Niewold T. B., Age- and gender-specific modulation of serum osteopontin and interferon- by osteopontin genotype in systemic lupus erythematosus Genes and Immunity 2009 10 5 487 494
72. Ronnblom L. E., Alm G. V., Oberg K. E., Possible induction of systemic lupus erythematosus by interferon -treatment in a patient with a malignant carcinoid tumour Journal of Internal Medicine 1990 227 3 207 210
73. Niewold T. B., Swedler W. I., Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C Clinical Rheumatology 2005 24 2 178 181
74. Ioannou Y., Isenberg D. A., Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy Arthritis and Rheumatism 2000 43 7 1431 1442
75. Gota C., Calabrese L., Induction of clinical autoimmune disease by therapeutic interferon- Autoimmunity 2003 36 8 511 518
76. Tan E. M., Cohen A. S., Fries J. F., The 1982 revised criteria for the classification of systemic lupus erythrematosus Arthritis and Rheumatism 1982 25 11 1271 1277
77. Ho V., McLean A., Terry S., Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C Journal of Clinical Rheumatology 2008 14 3 166 168
78. Niewold T. B., Interferon alpha-induced lupus: proof of principle Journal of Clinical Rheumatology 2008 14 3 131 132
79. Niewold T. B., Hua J., Lehman T. J. A., Harley J. B., Crow M. K., High serum IFN- activity is a heritable risk factor for systemic lupus erythematosus Genes and Immunity 2007 8 6 492 502
80. Niewold T. B., Adler J. E., Glenn S. B., Lehman T. J. A., Harley J. B., Crow M. K., Age- and sex-related patterns of serum interferon- activity in lupus families Arthritis and Rheumatism 2008 58 7 2113 2119
81. Weckerle C. E., Niewold T. B., The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clinical Reviews in Allergy and Immunology, 2010. In press
82. Kirou K. A., Lee C., George S., Louca K., Peterson M. G. E., Crow M. K., Activation of the interferon- pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease Arthritis and Rheumatism 2005 52 5 1491 1503
83. Dall'Era M. C., Cardarelli P. M., Preston B. T., Witte A., Davis J. C. Jr., Type I interferon correlates with serological and clinical manifestations of SLE Annals of the Rheumatic Diseases 2005 64 12 1692 1697
84. Feng X., Wu H., Grossman J. M., Hanvivadhanakul P., FitzGerald J. D., Park G. S., Dong X., Chen W., Kim M. H., Weng H. H., Furst D. E., Gorn A., McMahon M., Taylor M., Brahn E., Hahn B. H., Tsao B. P., Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus Arthritis and Rheumatism 2006 54 9 2951 2962
85. Zhuang H., Narain S., Sobel E., Lee P. Y., Nacionales D. C., Kelly K. M., Richards H. B., Segal M., Stewart C., Satoh M., Reeves W. H., Association of anti-nucleoprotein autoantibodies with upregulation of type I interferon-inducible gene transcripts and dendritic cell maturation in systemic lupus erythematosus Clinical Immunology 2005 117 3 238 250
86. Landolt-Marticorena C., Bonventi G., Lubovich A., Ferguson C., Unnithan T., Su J., Gladman D. D., Urowitz M., Fortin P. R., Wither J., Lack of association between the interferon- signature and longitudinal changes in disease activity in systemic lupus erythematosus Annals of the Rheumatic Diseases 2009 68 9 1440 1446
87. Petri M., Singh S., Tesfasyone H., Dedrick R., Fry K., Lal P. G., Williams G., Bauer J. W., Gregersen P. K., Behrens T. W., Baechler E. C., Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus Lupus 2009 18 11 980 989
88. Bauer J. W., Petri M., Batliwalla F. M., Koeuth T., Wilson J., Slattery C., Panoskaltsis-Mortari A., Gregersen P. K., Behrens T. W., Baechler E. C., Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study Arthritis and Rheumatism 2009 60 10 3098 3107
89. Yao Y., Richman L., Higgs B. W., Morehouse C. A., De Los Reyes M., Brohawn P., Zhang J., White B., Coyle A. J., Kiener P. A., Jallal B., Neutralization of interferon- / -inducible genes and downstream effect in a phase I trial of an anti-interferon- monoclonal antibody in systemic lupus erythematosus Arthritis and Rheumatism 2009 60 6 1785 1796